Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.

Decourcelle A, Loison I, Baldini S, Leprince D, Dehennaut V.

Biochem Biophys Res Commun. 2019 Oct 17. pii: S0006-291X(19)31983-7. doi: 10.1016/j.bbrc.2019.10.090. [Epub ahead of print]

PMID:
31630803
2.

Regulation of Polycomb Repression by O-GlcNAcylation: Linking Nutrition to Epigenetic Reprogramming in Embryonic Development and Cancer.

Decourcelle A, Leprince D, Dehennaut V.

Front Endocrinol (Lausanne). 2019 Feb 27;10:117. doi: 10.3389/fendo.2019.00117. eCollection 2019. Review.

3.

Cyclin D1 Stability Is Partly Controlled by O-GlcNAcylation.

Masclef L, Dehennaut V, Mortuaire M, Schulz C, Leturcq M, Lefebvre T, Vercoutter-Edouart AS.

Front Endocrinol (Lausanne). 2019 Feb 22;10:106. doi: 10.3389/fendo.2019.00106. eCollection 2019.

4.

HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs).

Paget S, Dubuissez M, Dehennaut V, Nassour J, Harmon BT, Spruyt N, Loison I, Abbadie C, Rood BR, Leprince D.

Oncotarget. 2017 Jan 10;8(2):2916-2935. doi: 10.18632/oncotarget.13807.

5.

Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines.

Steenackers A, Olivier-Van Stichelen S, Baldini SF, Dehennaut V, Toillon RA, Le Bourhis X, El Yazidi-Belkoura I, Lefebvre T.

Front Endocrinol (Lausanne). 2016 May 25;7:46. doi: 10.3389/fendo.2016.00046. eCollection 2016.

6.

Detection and identification of O-GlcNAcylated proteins by proteomic approaches.

Vercoutter-Edouart AS, El Yazidi-Belkoura I, Guinez C, Baldini S, Leturcq M, Mortuaire M, Mir AM, Steenackers A, Dehennaut V, Pierce A, Lefebvre T.

Proteomics. 2015 Mar;15(5-6):1039-50. doi: 10.1002/pmic.201400326. Epub 2015 Feb 3. Review.

PMID:
25429863
7.

O-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group Proteins.

Dehennaut V, Leprince D, Lefebvre T.

Front Endocrinol (Lausanne). 2014 Sep 26;5:155. doi: 10.3389/fendo.2014.00155. eCollection 2014. Review.

8.

O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41.

Olivier-Van Stichelen S, Dehennaut V, Buzy A, Zachayus JL, Guinez C, Mir AM, El Yazidi-Belkoura I, Copin MC, Boureme D, Loyaux D, Ferrara P, Lefebvre T.

FASEB J. 2014 Aug;28(8):3325-38. doi: 10.1096/fj.13-243535. Epub 2014 Apr 17.

9.

Cryptosporidium parvum-induced ileo-caecal adenocarcinoma and Wnt signaling in a mouse model.

Benamrouz S, Conseil V, Chabé M, Praet M, Audebert C, Blervaque R, Guyot K, Gazzola S, Mouray A, Chassat T, Delaire B, Goetinck N, Gantois N, Osman M, Slomianny C, Dehennaut V, Lefebvre T, Viscogliosi E, Cuvelier C, Dei-Cas E, Creusy C, Certad G.

Dis Model Mech. 2014 Jun;7(6):693-700. doi: 10.1242/dmm.013292. Epub 2014 Mar 20.

10.

The Reelin receptors ApoER2 and VLDLR are direct target genes of HIC1 (Hypermethylated In Cancer 1).

Dubuissez M, Faiderbe P, Pinte S, Dehennaut V, Rood BR, Leprince D.

Biochem Biophys Res Commun. 2013 Oct 25;440(3):424-30. doi: 10.1016/j.bbrc.2013.09.091. Epub 2013 Sep 25.

PMID:
24076391
11.

Proteomics and PUGNAcity will overcome questioning of insulin resistance induction by nonselective inhibition of O-GlcNAcase.

Dehennaut V, Lefebvre T.

Proteomics. 2013 Oct;13(20):2944-6. doi: 10.1002/pmic.201300363.

PMID:
23983178
12.

O-GlcNAcylation: A New Cancer Hallmark?

Fardini Y, Dehennaut V, Lefebvre T, Issad T.

Front Endocrinol (Lausanne). 2013 Aug 12;4:99. doi: 10.3389/fendo.2013.00099. eCollection 2013.

13.

A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis.

Sun L, Li H, Chen J, Dehennaut V, Zhao Y, Yang Y, Iwasaki Y, Kahn-Perles B, Leprince D, Chen Q, Shen A, Xu Y.

J Natl Cancer Inst. 2013 Jun 19;105(12):887-98. doi: 10.1093/jnci/djt118. Epub 2013 May 23.

PMID:
23704280
14.

Insulin signaling controls the expression of O-GlcNAc transferase and its interaction with lipid microdomains.

Perez-Cervera Y, Dehennaut V, Aquino Gil M, Guedri K, Solórzano Mata CJ, Olivier-Van Stichelen S, Michalski JC, Foulquier F, Lefebvre T.

FASEB J. 2013 Sep;27(9):3478-86. doi: 10.1096/fj.12-217984. Epub 2013 May 20.

PMID:
23689613
15.

DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair.

Dehennaut V, Loison I, Dubuissez M, Nassour J, Abbadie C, Leprince D.

J Biol Chem. 2013 Apr 12;288(15):10254-64. doi: 10.1074/jbc.M112.421610. Epub 2013 Feb 15.

16.

Identification of p21 (CIP1/WAF1) as a direct target gene of HIC1 (Hypermethylated In Cancer 1).

Dehennaut V, Loison I, Boulay G, Van Rechem C, Leprince D.

Biochem Biophys Res Commun. 2013 Jan 4;430(1):49-53. doi: 10.1016/j.bbrc.2012.11.045. Epub 2012 Nov 22.

PMID:
23178572
17.

Molecular dissection of the interaction between HIC1 and SIRT1.

Dehennaut V, Loison I, Pinte S, Leprince D.

Biochem Biophys Res Commun. 2012 May 4;421(2):384-8. doi: 10.1016/j.bbrc.2012.04.026. Epub 2012 Apr 9.

PMID:
22510409
18.

Serum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression.

Olivier-Van Stichelen S, Drougat L, Dehennaut V, El Yazidi-Belkoura I, Guinez C, Mir AM, Michalski JC, Vercoutter-Edouart AS, Lefebvre T.

Oncogenesis. 2012 Dec 10;1:e36. doi: 10.1038/oncsis.2012.36.

19.

Direct evidence of O-GlcNAcylation in the apicomplexan Toxoplasma gondii: a biochemical and bioinformatic study.

Perez-Cervera Y, Harichaux G, Schmidt J, Debierre-Grockiego F, Dehennaut V, Bieker U, Meurice E, Lefebvre T, Schwarz RT.

Amino Acids. 2011 Mar;40(3):847-56. doi: 10.1007/s00726-010-0702-4. Epub 2010 Jul 27.

PMID:
20661758
20.

Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response.

Dehennaut V, Leprince D.

Bull Cancer. 2009 Nov;96(11):E66-72. doi: 10.1684/bdc.2009.0959. Review.

21.

Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease.

Lefebvre T, Dehennaut V, Guinez C, Olivier S, Drougat L, Mir AM, Mortuaire M, Vercoutter-Edouart AS, Michalski JC.

Biochim Biophys Acta. 2010 Feb;1800(2):67-79. doi: 10.1016/j.bbagen.2009.08.008. Epub 2009 Sep 2. Review.

PMID:
19732809
22.

Survey of O-GlcNAc level variations in Xenopus laevis from oogenesis to early development.

Dehennaut V, Lefebvre T, Leroy Y, Vilain JP, Michalski JC, Bodart JF.

Glycoconj J. 2009 Apr;26(3):301-11. doi: 10.1007/s10719-008-9166-0. Epub 2008 Jul 17.

PMID:
18633701
23.

Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte.

Dehennaut V, Slomianny MC, Page A, Vercoutter-Edouart AS, Jessus C, Michalski JC, Vilain JP, Bodart JF, Lefebvre T.

Mol Cell Proteomics. 2008 Nov;7(11):2229-45. doi: 10.1074/mcp.M700494-MCP200. Epub 2008 Jul 9.

24.

Protein ubiquitination is modulated by O-GlcNAc glycosylation.

Guinez C, Mir AM, Dehennaut V, Cacan R, Harduin-Lepers A, Michalski JC, Lefebvre T.

FASEB J. 2008 Aug;22(8):2901-11. doi: 10.1096/fj.07-102509. Epub 2008 Apr 23.

PMID:
18434435
25.

Microinjection of recombinant O-GlcNAc transferase potentiates Xenopus oocytes M-phase entry.

Dehennaut V, Hanoulle X, Bodart JF, Vilain JP, Michalski JC, Landrieu I, Lippens G, Lefebvre T.

Biochem Biophys Res Commun. 2008 May 2;369(2):539-46. doi: 10.1016/j.bbrc.2008.02.063. Epub 2008 Feb 25.

PMID:
18298951
26.

O-linked N-acetylglucosaminyltransferase inhibition prevents G2/M transition in Xenopus laevis oocytes.

Dehennaut V, Lefebvre T, Sellier C, Leroy Y, Gross B, Walker S, Cacan R, Michalski JC, Vilain JP, Bodart JF.

J Biol Chem. 2007 Apr 27;282(17):12527-36. Epub 2007 Feb 28.

27.

Does O-GlcNAc play a role in neurodegenerative diseases?

Lefebvre T, Guinez C, Dehennaut V, Beseme-Dekeyser O, Morelle W, Michalski JC.

Expert Rev Proteomics. 2005 Apr;2(2):265-75. Review.

PMID:
15892570

Supplemental Content

Loading ...
Support Center